INEGY 10 MG/10 MG TABLETS

국가: 이스라엘

언어: 영어

출처: Ministry of Health

유효 성분:

EZETIMIBE 10 MG; SIMVASTATIN 10 MG

제공처:

MERCK SHARP & DOHME ISRAEL LTD

ATC 코드:

C10AA01

약제 형태:

TABLETS

관리 경로:

PER OS

Manufactured by:

MERCK SHARP & DOHME (ITALIA) S.P.A.

치료 그룹:

SIMVASTATIN

치료 징후:

Hypercholesterolemia: Inegy is indicated as adjunctive therapy to diet for use in patients with primary ( heterozygous familial and nonfamilial) hypercholesterolemia or mixed hyperlipidemia where use of a combination product is appropriate: - patients not appropriately controlled with a statin alone - patients already treated with a statin and ezetimibe. Inegy contains ezetimibe and simvastatin. Simvastatin ( 20 - 40 mg ) has been shown to reduce the frequency of cardiovascular events. Studies to demonstrate the efficacy of inegy or ezetimibe in the prevention of complications of atherosclerosis have not been completed. Homozygous familial hypercholesterolemia (HoFH): Inegy is indicated as adjunctive therapy to diet for use in patients with HoFH.Patients may also receive adjunctive treatments ( e.g. low-density lipoprotein [LDL] apheresis).

승인 날짜:

2012-04-01